AbCellera Biologics Inc. ABCL Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s other income (expense)?
- AbCellera Biologics Inc. (ABCL) reported other income (expense) of $7.98M in Q1 2026.
- How has AbCellera Biologics Inc.'s other income (expense) changed year-over-year?
- AbCellera Biologics Inc.'s other income (expense) decreased by 17.5% year-over-year, from $9.68M to $7.98M.
- What is the long-term trend for AbCellera Biologics Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s other income (expense) has grown at a 28.1% compound annual growth rate (CAGR), from $14.65M to $39.51M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.